Physician profile
Alan C Mccool
NPI 1811940679
$7,215.23
in general payments reported to CMS, 2019-2025
25 companies · $1,250 in 2025
The $1,250 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $527 · 2020: $195 · 2021: $569 · 2022: $845 · 2023: $685 · 2024: $3,145 · 2025: $1,250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,977 · Long Term Medical Supply Or Device Loan: $1,980 · Education: $123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,977.30 |
| Long Term Medical Supply Or Device Loan | $1,979.81 |
| Education | $122.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,979.81 | 2024 | Integra |
| Coloplast Corp | $1,492.14 | 2019-2025 | Titan, Virtue, Genesis |
| Medtronic, INC. | $1,243.44 | 2022-2025 | Interstim |
| Axonics, INC. | $967.72 | 2020-2024 | Axonics, Bulkamid |
| Boston Scientific Corporation | $468.12 | 2019-2025 | Solyx Sis System, Upsylon, Lithovue |
| Olympus America INC. | $257.62 | 2024-2025 | Itind System, Soltive, Bovie |
| Intuitive Surgical, INC. | $233.50 | 2021-2024 | |
| Astellas Pharma US INC | $99.99 | 2021 | |
| Janssen Biotech, INC. | $81.66 | 2025 | Erleada, Carvykti, Rybrevant |
| Conmed Corporation | $47.92 | 2023-2024 | Airseal |
| Ferring Pharmaceuticals INC. | $45.13 | 2025 | Adstiladrin |
| Astrazeneca Pharmaceuticals Lp | $35.06 | 2025 | Imfinzi |
| Calyxo, INC. | $32.02 | 2025 | Cvac Aspiration System |
| Teleflex LLC | $27.00 | 2025 | Barrigel |
| Urogen Pharma, INC. | $24.37 | 2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $23.68 | 2025 | Prolaris |
| Bluewind Medical | $23.50 | 2024 | Revi |
| Travere Therapeutics, INC. | $19.13 | 2025 | Thiola |
| Pfizer INC. | $18.44 | 2025 | |
| Antares Pharma, INC. | $18.28 | 2025 | Xyosted |
| Procept Biorobotics Corporation | $17.58 | 2024 | Aquabeam System |
| Abc Home Medical Supply, INC. | $16.45 | 2025 | |
| Ambu INC. | $15.31 | 2025 | |
| Cook Medical LLC | $15.00 | 2025 | Ncircle |
| Medtronic USA, INC. | $12.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Mccool listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.